We are live on
!
Find out more
BIA
Biondo Investment Advisors Portfolio holdings
AUM
$780M
1-Year Est. Return
21.03%
This Fund
S&P 500
This Quarter
Est. Return
+12.45%
1 Year Est. Return
+21.03%
3 Year Est. Return
+89.14%
5 Year Est. Return
+116.93%
10 Year Est. Return
+716.27%
AUM
$582M
AUM Growth
+$80M
(+16%)
Cap. Flow
+$42.6M
Cap. Flow
% of AUM
7.33%
Top 10 Holdings %
Top 10 Hldgs %
46.49%
Holding
88
New
7
Increased
46
Reduced
20
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$21.7M |
| 2 |
Amazon
AMZN
|
+$10.1M |
| 3 |
Teladoc Health
TDOC
|
+$5.95M |
| 4 |
Moderna
MRNA
|
+$4.34M |
| 5 |
BioCryst Pharmaceuticals
BCRX
|
+$3.61M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$6.88M |
| 2 |
Church & Dwight Co
CHD
|
+$6.31M |
| 3 |
ServiceNow
NOW
|
+$1.28M |
| 4 |
Atlassian
TEAM
|
+$1.04M |
| 5 |
Adobe
ADBE
|
+$340K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 36.27% |
| 2 | Technology | 19.97% |
| 3 | Consumer Discretionary | 11.21% |
| 4 | Financials | 10.59% |
| 5 | Communication Services | 5.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
10x Genomics
TXG
$5.79B
| $333K | 0.06% |
1,700
| – | – |
|
77
Visa
V
$692B
| $330K | 0.06% |
1,410
| – | – |
|
78
iShares Core S&P US Growth ETF
IUSG
$33.4B
| $279K | 0.05% |
2,767
+50
| +2% | +$4.82K |
|
79
Invesco QQQ Trust
QQQ
$479B
| $266K | 0.05% |
750
| – | – |
|
80
Energy Transfer Partners
ET
$71.2B
| $249K | 0.04% |
23,460
| – | – |
|
81
Regeneron Pharmaceuticals
REGN
$79.5B
| $235K | 0.04% |
+420
| New | +$213K |
|
82
iShares Core MSCI EAFE ETF
IEFA
$194B
| $227K | 0.04% |
3,029
| – | – |
|
|
BNY
83
Bank of New York Mellon
BNY
$108B
| $205K | 0.04% |
+4,000
| New | +$200K |
|
|
MCI
84
Barings Corporate Investors
MCI
$343M
| $198K | 0.03% |
13,000
-2,000
| -13% | -$29.6K |
|
|
85
Church & Dwight Co
CHD
$24.5B
| – | – |
-72,007
| Closed | -$6.31M |
|
|
86
ServiceNow
NOW
$121B
| – | – |
-12,825
| Closed | -$1.28M |
|
|
87
Vertex Pharmaceuticals
VRTX
$123B
| – | – |
-32,026
| Closed | -$6.88M |
|
Similar funds
LA
SG
RTM
TCMX
QCMNJ
TIS
MO
NCM
Biondo Investment Advisors's Q2 2021 Portfolio in Review
As of Q2 2021, Biondo Investment Advisors held 88 positions worth $582M, up 16% from $502M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Biondo Investment Advisors deployed $42.6M of net new capital in Q2 2021, opening 7 new positions and adding to 46 existing holdings. Its largest new stake was NVIDIA: 1,351,200 shares worth $6.76M.
By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 34% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Atlassian, an estimated $1.04M trimmed.
- Biondo Investment Advisors's largest Q2 2021 buy was NVIDIA: 1,351,200 shares worth $6.76M.
- Biondo Investment Advisors added most to Amazon in Q2 2021, an estimated $10.1M increase.
- Biondo Investment Advisors's biggest Q2 2021 reduction was Atlassian, cutting an estimated $1.04M.
- Biondo Investment Advisors fully exited Vertex Pharmaceuticals in Q2 2021, selling an estimated $6.88M.
- Biondo Investment Advisors's ten largest holdings make up 46% of its $582M portfolio in Q2 2021.
- Biondo Investment Advisors opened 7 new positions and closed 3 in Q2 2021.
- Biondo Investment Advisors's portfolio value rose 16% quarter-over-quarter to $582M.
Based on Biondo Investment Advisors's 13F filing for Q2 2021, filed 3 Aug 2021.